Activated CD8⁺HLA-DR⁺ T Cells as Immune Biomarkers of Metabolic Dysfunction and Cardiovascular Risk in Prediabetes
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background Prediabetes is characterized by metabolic dysfunction and chronic low-grade inflammation, both of which contribute to β-cell impairment and elevated cardiovascular risk. While activated CD8⁺ T cells expressing HLA-DR (CD8⁺HLA-DR⁺) have been implicated in obesity-related inflammation, their role in prediabetes remains undefined. Methods In this cross-sectional study, overweight and obese adults (BMI ≥ 25 kg/m²) were stratified into three groups: lean healthy (LH), metabolically healthy overweight/obese (HO), and prediabetic overweight/obese (Pre-OB). Peripheral blood mononuclear cells were analyzed by flow cytometry to quantify CD8⁺HLA-DR⁺ T cells. Circulating cytokines and metabolic markers, including fasting glucose, insulin, C-peptide, lipid profiles, and β-cell function (HOMA-B%), were measured. Correlations with cardiovascular risk markers were evaluated. Results The frequency of CD8⁺HLA-DR⁺ T cells was significantly higher in Pre-OB individuals compared to HO and LH groups (p < 0.001). These cells positively correlated with fasting C-peptide (r = 0.32, p = 0.03) and inversely with HOMA-B% (r = − 0.35, p = 0.02), indicating a link with β-cell dysfunction. CD8⁺HLA-DR⁺ T cells also correlated with inflammatory cytokines (IL-6, TNF-α, IFN-γ) and cardiovascular risk markers including diastolic blood pressure, triglycerides, and MMP-9 (all p < 0.05). Conclusions Activated CD8⁺HLA-DR⁺ T cells are significantly enriched in obese individuals with prediabetes and are associated with markers of β-cell dysfunction, systemic inflammation, and cardiovascular risk. These findings identify CD8⁺HLA-DR⁺ T cells as potential immune biomarkers for early cardiometabolic deterioration and targets for preventative strategies in high-risk prediabetic populations.